Experimenter at tissue culture hood MI-mAbs


With the opening of its building, MI-mAbs, the french demonstrator of immunotherapy antibodies embarks on a new phase of growth

- A surface area of 1,500 square meters, this building, the property of Aix-Marseille Provence Metropolis was…

Read more  

MI-mAbs accelerates Immuno Oncology discovery

Interview by Pieter Droppert, Biotech Strategy Blog Author

Read more  

MI-mAbs signed a research contract to evaluate novel bispecific antibodies co-developed by Innate Pharma and Sanofi

This contract follows the agreement announced by Innate Pharma and Sanofi last January on the development of novel…

Read more  

Launch of MI-mAbs, pre-industrial demonstrator accelerating development of immunotherapy antibodies

Signature of the consortium agreement between key players in science, translational research and industry of cancer and…

Read more